Consenso nacional sobre "H. pylori" e afecçöes associadas

Coelho, Luiz Gonzaga Vaz; Barros, Carlos Alberto Silva; Lima, David Corrêa Alves de; Barbosa, Alfredo J. A; Magalhäes, Antônio Frederico N; Oliveira, Celso Affonso de; Queiroz, Dulciene M. M; Cordeiro, Fernando; Rezende, Joffre M; Castro, Luiz de Paula; Tolentino, Márcio M; Haddad, Marcus Tulio; Zaterka, Schlioma.
GED gastroenterol. endosc. dig ; 15(2): 53-8, mar.-abr. 1996. tab
Artículo en Portugués | LILACS | ID: lil-170101

Documentos relacionados

  1. Comparison of vonoprazan dual therapy, quadruple therapy and standard quadruple therapy for Helicobacter pylori infection in Hainan: a single-center, open-label, non-inferiority, randomized controlled trial.
  2. [Quadruple treatment with doxycycline, furazolidone, bismuth and proton pump inhibitor is still effective against Helicobacter pylori in our population].
  3. Quadruple therapy with vonoprazan 20 mg daily as a first-line treatment for Helicobacter pylori infection: A single-center, open-label, noninferiority, randomized controlled trial.
  4. Antibiotic resistance status of helicobacter pylori strains isolated from initial eradication patients in Ningbo, China, from 2017 to 2021.
  5. [Efficacy of bismuth containing quadruple therapies on Helicobacter pylori eradication in patients with history of antibiotic treatment].
  6. Host Cell Antimicrobial Responses against <i>Helicobacter pylori</i> Infection: From Biological Aspects to Therapeutic Strategies.
  7. Characteristics of phenotypic antibiotic resistance of Helicobacter pylori and its correlation with genotypic antibiotic resistance: A retrospective study in Ningxia.
  8. Furazolidone-containing triple and quadruple eradication therapy for initial treatment for Helicobacter pylori infection: A multicenter randomized controlled trial in China.
  9. [Efficacy and safety of 14-day amoxicillin and furazolidone-based quadruple rescue regimen for eradication of Helicobacter pylori: a retrospective study].
  10. Adherence to international guidelines for the management of Helicobacter pylori infection among gastroenterologists and gastroenterology fellows in Italy: A Survey of the Italian Federation of Digestive Diseases - FISMAD.